Bradford Hill Seminar – The future of cancer screening: stratified, pan, both or neither?

Wed 11 May 2022

online

In this seminar Professor Peter Sasieni of King’s Clinical Trials Unit, King’s College London, will briefly review the current landscape regarding cancer screening.

He will then consider the potential for stratifying screening using either polygenic risk scores to differentiate between those with a low, average, or high risk of cancer, or the post-test risk of cancer to offer stratified management.

Finally, he will review the potential to expand the scope of cancer screening by adding either new single-site screening programmes or a multi-cancer early detection test. The question of whether a pan-cancer screening test would dissipate the benefit of using polygenic risk scores to stratify screening will also be discussed as will the challenges of reducing screening as risk changes.

Cost: Free